Merilog will be provided by prefilled pen in a 3 mL dose or in a multiple-dose 10 mL vial. It is for adults ... a planned 75% reduction in the cost of NovoLog. Then a few days later, Sanofi ...

Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog ... and 10 mL multiple-dose vial versions of the drug.

and a 10ml multiple-dose vial should be administered by subcutaneous injection within five to 10 minutes before the start of a meal. NovoLog is also available in pen injector formats. Before ...

Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.

Insulin as part (rDNA origin) injection Novolog (Novo Nordisk) 28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

The U.S. Food and Drug Administration has approved Sanofi-Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin ... and a 10-mL multiple-dose vial are included in this ...

The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement ... pen and a 10 milliliter multiple-dose vial. Merilog is the third insulin biosimilar product ...

Merilog (insulin-aspart-szjj, Sanofi-Aventis U.S.) was approved as biosimilar to Novolog (Novo Nordisk ... three mL pen and a 10 mL multi-dose vial. “For the millions of people who rely on ...

WEDNESDAY, Feb. 19, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart ... pen and a 10-mL ...